NL-OMON37893已完成不适用
T cell-mediated immunity targeting polyomavirus BK - Not applicable
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Being a kidney transplant recipient treated according to the standard treatment protocols applying to kidney transplant recipients treated in the Academic medical Centre Amsterdam.
- •- Age equal- to or older than eighteen years.
排除标准
- •Age under eighteen years.
研究者
相似试验
招募中
1 期
Adoptive T-cell Therapy for Resistant Viral Infections After Allogeneic HSCT ( VS-TC )Patients who have received an allogeneic haematopoietic stem cell transplant and who have developed post-transplant viral reactivation (CMV, Adenovirus, EBV) resistant to pharmacological therapiesMedDRA version: 20.1Level: PTClassification code 10056559Term: Graft infectionSystem Organ Class: 10021881 - Infections and infestationsEUCTR2021-005150-28-ITIRCCS ISTITUTO GIANNINA GASLINI10
进行中（未招募）
1 期
CMV specific T cell therapy for the treatment of relapsing or therapy refractory CMV infection after allogeneic stem cell transplantation with a CMV-positive donor.EUCTR2013-004953-26-BEGhent University Hospital20
已完成
1 期
Epstein-Barr Virus (EBV) -specific T cells as therapy for relapsed / refractory EBV-positive lymphomasRelapsed or refractory EBV-positive lymphomaBlood - Haematological diseasesACTRN12608000521325Queensland Institute of Medical Research (QIMR)20
招募中
不适用
Prospective Clinical trial of BK polyomavirus (BKPyV) infections in adult kidney transplanted patientsN14.2Nephropathy induced by unspecified drug, medicament or biological substanceDRKS00019911niversitätsmedizin Rostock,Urologische Klinik und Poliklinik50
招募中
不适用
Development of novel immunotherapy using NKT cells for malignant solid tumors in childreHealthy volunteersJPRN-UMIN000048076Chiba University30